Avid Bioservices, Inc. Quarterly Deferred Income Tax Assets, Net in USD from Q1 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Avid Bioservices, Inc. quarterly Deferred Income Tax Assets, Net history and growth rate from Q1 2021 to Q4 2023.
  • Avid Bioservices, Inc. Deferred Income Tax Assets, Net for the quarter ending January 31, 2024 was $118M, a 2.64% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $118M +$3.03M +2.64% Jan 31, 2024 10-Q 2024-04-24
Q3 2023 $117M -$817K -0.7% Oct 31, 2023 10-Q/A 2024-04-24
Q2 2023 $114M -$149K -0.13% Jul 31, 2023 10-Q/A 2024-04-24
Q1 2023 $114M -$1.33M -1.16% Apr 30, 2023 10-K 2024-07-02
Q4 2022 $115M Jan 31, 2023 10-K/A 2024-04-24
Q3 2022 $118M Oct 31, 2022 10-K/A 2024-04-24
Q2 2022 $115M Jul 31, 2022 10-K/A 2024-04-24
Q1 2022 $115M +$115M Apr 30, 2022 10-K/A 2024-04-24
Q1 2021 $0 Apr 30, 2021 10-K 2022-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.